Davis CL, Gonwa TA, Wilkinson AH. Pathophysiology of renal disease associated with liver disorders: implications for liver transplantation. Part I. Liver Transpl 2002; 8: 91-109.
Davis CL, Gonwa TA, Wilkinson AH. Pathophysiology of renal disease associated with liver disorders: implications for liver transplantation. Part I. Liver Transpl 2002; 8: 91-109.
2
30444446685
Impact of pretransplant renal failure: When is listing for kidney-liver indicated?
Davis CL. Impact of pretransplant renal failure: when is listing for kidney-liver indicated? Liver Transpl 2005; 11(11 Suppl 2): S35-44.
Impact of pretransplant renal function on survival after liver transplantation
Gonwa TA, Klintmalm GB, Levy M, Jennings LS, Goldstein RM, Husberg BS. Impact of pretransplant renal function on survival after liver transplantation. Transplantation 1995; 59: 361-5.
Identification of patients best suited for combined liver-kidney transplantation: Part II
Davis CL, Gonwa TA, Wilkinson AH. Identification of patients best suited for combined liver-kidney transplantation: part II. Liver Transpl 2002; 8: 193-211.
Sollinger HW. Mycophenolates in transplantation. Clin Transplant 2004; 18: 485-92.
Sollinger HW. Mycophenolates in transplantation. Clin Transplant 2004; 18: 485-92.
11
33748804924
Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in liver transplant patients presenting gastrointestinal disorders: A pilot study
Dumortier J, Gagnieu MC, Salandre J, Guillaud O, Guillem P, Adham M, et al. Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in liver transplant patients presenting gastrointestinal disorders: a pilot study. Liver Transpl 2006; 12: 1342-6.